GB201312499D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB201312499D0
GB201312499D0 GBGB1312499.5A GB201312499A GB201312499D0 GB 201312499 D0 GB201312499 D0 GB 201312499D0 GB 201312499 A GB201312499 A GB 201312499A GB 201312499 D0 GB201312499 D0 GB 201312499D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1312499.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1312499.5A priority Critical patent/GB201312499D0/en
Publication of GB201312499D0 publication Critical patent/GB201312499D0/en
Priority to PCT/GB2014/052143 priority patent/WO2015004485A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB1312499.5A 2013-07-12 2013-07-12 Therapeutic compounds Ceased GB201312499D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1312499.5A GB201312499D0 (en) 2013-07-12 2013-07-12 Therapeutic compounds
PCT/GB2014/052143 WO2015004485A1 (en) 2013-07-12 2014-07-14 Therapeutic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1312499.5A GB201312499D0 (en) 2013-07-12 2013-07-12 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB201312499D0 true GB201312499D0 (en) 2013-08-28

Family

ID=49081184

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1312499.5A Ceased GB201312499D0 (en) 2013-07-12 2013-07-12 Therapeutic compounds

Country Status (2)

Country Link
GB (1) GB201312499D0 (en)
WO (1) WO2015004485A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11930815B1 (en) 2023-08-29 2024-03-19 King Faisal University 3,3′-(piperazine-1,4-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as insecticidal agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU753706B2 (en) * 1998-05-14 2002-10-24 Egis Gyogyszergyar Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
EP1940373B8 (en) * 2005-10-13 2015-06-24 Waratah Pharmaceuticals, Inc. 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
US20100279997A1 (en) * 2009-05-04 2010-11-04 Lindsay Burns Barbier Analgesic that binds filamin a
KR101476379B1 (en) * 2011-11-30 2014-12-29 한국과학기술연구원 Derivatives of 1-Phenoxy propan-2-ol and pharmaceutical composition containing the same
WO2014011917A2 (en) * 2012-07-13 2014-01-16 Pain Therapeutics, Inc. A method of inhibiting tau phosphorylation

Also Published As

Publication number Publication date
WO2015004485A1 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
GB201321746D0 (en) Therapeutic agents
GB201321743D0 (en) Therapeutic agents
GB201321736D0 (en) Therapeutic agents
GB201321738D0 (en) Therapeutic Agents
GB201321729D0 (en) Therapeutic agents
GB201321733D0 (en) Therapeutic agents
AP2015008713A0 (en) Tetrahydropyrrolothiazine compounds
GB201321728D0 (en) Therapeutic agents
GB201321739D0 (en) Therapeutic agents
GB201321730D0 (en) Therapeutic agents
GB201321741D0 (en) Therapeutic agents
GB201321740D0 (en) Therapeutic agents
GB201321732D0 (en) Therapeutic agents
GB201321734D0 (en) Therapeutic Agents
GB201321737D0 (en) Therapeutic Agents
GB201321744D0 (en) Therapeutic agents
GB201321742D0 (en) Therapeutic agents
GB201321735D0 (en) Therapeutic Agents
GB201321745D0 (en) Therapeutic agents
GB201308440D0 (en) Therapeutic
GB201321748D0 (en) Therapeutic agents
GB201321731D0 (en) Therapeutic agents
AP3850A (en) Azetidinyloxyphenylpyrrolidine compounds
GB201321749D0 (en) Therapeutic agents
GB201310755D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)